In contrast with previous work by Lai (2008), ▶ our finding demonstrated the effectiveness of ascorbic acid alone in reducing fasting insulin and HOMA-IR% in type 2 diabetes patients. This evidence concerns the gene INS and type 2 diabetes mellitus.